Jane Street’s Soleno Therapeutics SLNO Stock Holding History

Jane Street’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.35M	Buy	279,200 +191,700	+219%	+$7.52M	﹤0.01%	2621
2025 Q4	$4.05M	Sell	87,500 -17,700	-17%	-$970K	﹤0.01%	3565
2025 Q3	$7.11M	Sell	105,200 -79,400	-43%	-$5.89M	﹤0.01%	2895
2025 Q2	$15.5M	Buy	184,600 +156,300	+552%	+$11.7M	﹤0.01%	1694
2025 Q1	$2.02M	Buy	28,300 +4,900	+21%	+$239K	﹤0.01%	4333
2024 Q4	$1.05M	Sell	23,400 -31,600	-57%	-$1.64M	﹤0.01%	5288
2024 Q3	$2.78M	Buy	+55,000	New	+$2.63M	﹤0.01%	3868

Other funds holding SLNO

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

KCM

Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

Jane Street's SLNO Position: Q1 2026 in Review

Jane Street reduced its Soleno Therapeutics (SLNO) stake by 92% in Q1 2026, selling an estimated $5.13M and leaving 11,002 shares worth $368K. The position accounts for ﹤0.01% of the portfolio, ranked #8761.

Jane Street first reported a position in SLNO in Q1 2015 and has held it in 13 quarters since. The position peaked at $6.56M in Q4 2025. 225 funds tracked by Wall St. Rank hold SLNO as of Q1 2026.

Jane Street held 11,002 shares of Soleno Therapeutics worth $368K as of Q1 2026.
Jane Street sold 130,738 Soleno Therapeutics shares in Q1 2026, an estimated $5.13M.
Soleno Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #8761 holding.
Jane Street first reported a position in Soleno Therapeutics in Q1 2015 and has held it in 13 quarters since.
Jane Street's Soleno Therapeutics position peaked at $6.56M in Q4 2025.
225 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.